Literature DB >> 8280706

Cytokine-induced tumor immunogenicity: from exogenous cytokines to gene therapy.

G Forni1, M Giovarelli, F Cavallo, M Consalvo, A Allione, A Modesti, P Musiani, M P Colombo.   

Abstract

The local presence of cytokines can drastically alter tumor host immune relations and activate a nonspecific reaction that in some cases leads to induction of specific responses to otherwise nonimmunogenic tumors. The employment of cytokines in the creation of new antitumor vaccines is thus a tempting prospect. Analogous effects have been obtained with cytokines inoculated locally and cytokines released from tumor cells engineered to produce them. An account is given of some mechanisms whereby this cytokine-induced reaction results in increased tumor immunogenicity. However, the real value of this potential form of vaccine in inducing the regression of incipient or established tumors remains to be established.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280706     DOI: 10.1097/00002371-199311000-00001

Source DB:  PubMed          Journal:  J Immunother Emphasis Tumor Immunol        ISSN: 1067-5582


  5 in total

Review 1.  Immunotherapy I: Cyclosine gene transfer strategies.

Authors:  M P Colombo; G Forni
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

2.  Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells.

Authors:  F O Nestle; G Burg; J Fäh; T Wrone-Smith; B J Nickoloff
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 3.  From in vitro to in vivo. Progress in the use of cultured cells for human therapy.

Authors:  W Dalemans
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

4.  In vivo infiltration of mononuclear cells in squamous cell carcinoma of the head and neck correlates with the ability to expand tumour-infiltrating T cells in vitro and with the expression of MHC class I antigens on tumour cells.

Authors:  J Hald; N Rasmussen; M H Claesson
Journal:  Cancer Immunol Immunother       Date:  1994-12       Impact factor: 6.968

5.  IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors.

Authors:  Shiguo Zhu; Dean Anthony Lee; Shulin Li
Journal:  J Immunol       Date:  2010-02-05       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.